E. Geissler

Validation of the R3-AFP model for risk prediction of HCC recurrence after liver transplantation in the SiLVER clinical trial
20230 citationsauthor #6
Donor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial.
202317 citationsauthor #8
Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy
20234 citationsauthor #8
Breaking primary checkpoint inhibitor resistance: Interim analysis of a multicenter phase II study by intermittent application of an alkylating agent among patients with metastatic melanoma.
20230 citationsauthor #5
Establishing Guidelines for Organ Donation Systems
20231 citationsauthor #1
Extrahepatic Bile Duct Organoids as a Model to Study Ischemia/Reperfusion Injury during Liver Transplantation
20230 citationsauthor #6
Case report: Predictability of clinical response and rejection risk after immune checkpoint inhibition in liver transplantation
20233 citationsauthor #7
Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection
20238 citationsauthor #6
External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition
202212 citationsauthor #8
Identification and Isolation of Type II NKT Cell Subsets in Human Blood and Liver
202211 citationsauthor #4
The Destiny of Articles When Pairing “Traditional”—With Open Access Sibling Journals
20220 citationsauthor #5
A non-canonical vitamin K cycle is a potent ferroptosis suppressor
2022513 citationsauthor #21
Effects of regulated cell death (e. g. ferroptosis) on early hepatic ischemia reperfusion damage in steatotic donor organs
20221 citationsauthor #4
Donor-But Not Recipient-Derived Cells Produce Collagen-1 in Chronically Rejected Cardiac Allografts
20222 citationsauthor #8
Editorial: Immunological Tolerance in Transplantation: More Than Deletion
20220 citationsauthor #3
The Role of Citrate Homeostasis in Merkel Cell Carcinoma Pathogenesis
20229 citationsauthor #6
Early γGT and bilirubin levels as biomarkers for regeneration and outcomes in damaged bile ducts after liver transplantation
20223 citationsauthor #10
A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.
202223 citationsauthor #18
Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis
202153 citationsauthor #23
Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications
20219 citationsauthor #9
Cancer-associated cells release citrate to support tumour metastatic progression
202132 citationsauthor #31
Successful auxiliary two-staged partial resection liver transplantation (ASPIRE-LTx) for end-stage liver disease to avoid small-for-size situations
202110 citationsauthor #6
Hepatocellular carcinoma progression during bridging before liver transplantation
20218 citationsauthor #6
Incidence and Mortality of Malignant Melanoma in Relation to Dermatologist Density in Bavaria
202110 citationsauthor #3
Steatotic Livers Are More Susceptible to Ischemia Reperfusion Damage after Transplantation and Show Increased γδ T Cell Infiltration
202112 citationsauthor #6
Potential involvement of extracellular citrate in brain tumor progression.
20219 citationsauthor #11
Extracellular Citrate Fuels Cancer Cell Metabolism and Growth
202032 citationsauthor #9
Anti-BAFF Treatment Interferes With Humoral Responses in a Model of Renal Transplantation in Rats
202013 citationsauthor #4
Differential effects of heat‐inactivated, secretome‐deficient MSC and metabolically active MSC in sepsis and allogenic heart transplantation
202027 citationsauthor #8
Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant Recipients
20202 citationsauthor #10
Randomized Sirolimus-based Early Calcineurin Inhibitor Reduction in Liver Transplantation: Impact on Renal Function
202015 citationsauthor #6
Transplantation Direct: TTS eJournal Progress Update.
20200 citationsauthor #1
The ONE Study: Evaluation of Regulatory Cell Therapy in Kidney Transplantation Using a Harmonized Trial Design
20204 citationsauthor #61
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials (vol 395, pg 1627, 2020)
20202 citationsauthor #61
Cross‐presentation of dead‐cell‐associated antigens by DNGR‐1+ dendritic cells contributes to chronic allograft rejection in mice
20208 citationsauthor #8
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.
2020330 citationsauthor #61
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors.
202097 citationsauthor #48
The Impact of COVID-19 on the State of Clinical and Laboratory Research Globally in Transplantation in May 2020
20204 citationsauthor #8
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
202092 citationsauthor #21
COVID-19: a year on.
20201 citationsauthor #5
HCC recurrence in HCV‐infected patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs – a post‐hoc analysis
20205 citationsauthor #7
Negative pressure wound therapy (NPWT) on closed incisions to prevent surgical site infection in high-risk patients in hepatopancreatobiliary surgery: study protocol for a randomized controlled trial—the NP-SSI trial
20205 citationsauthor #10
Human Tolerogenic Dendritic Cells Regulate Immune Responses through Lactate Synthesis.
201995 citationsauthor #18
Pressure distribution and flow characteristics during negative pressure wound therapy.
201914 citationsauthor #2
Oxygen levels during negative pressure wound therapy.
201917 citationsauthor #2
Collective cancer invasion forms an integrin-dependent radioresistant niche
201967 citationsauthor #11
Augmenter of Liver Regeneration Reduces Ischemia Reperfusion Injury by Less Chemokine Expression, Gr-1 Infiltration and Oxidative Stress
201916 citationsauthor #4
Can Mycophenolic Acid-based Immunosuppression Benefit Liver Transplant Patients With HCC?
20191 citationsauthor #1
Potential Use of Gluconate in Cancer Therapy
201929 citationsauthor #10
IL-3 Triggers Chronic Rejection of Cardiac Allografts by Activation of Infiltrating Basophils
201916 citationsauthor #13
Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective
201941 citationsauthor #7
Title Minimum Information about T Regulatory Cells : A Step toward Reproducibility and Standardization Permalink
20180 citationsauthor #17
Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers
201810 citationsauthor #11
TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity
2018113 citationsauthor #17
Murine DX5+NKT Cells Display Their Cytotoxic and Proapoptotic Potentials against Colitis-Inducing CD4+CD62Lhigh T Cells through Fas Ligand
20184 citationsauthor #5
Generation of TIGIT+ iTregs by Human Regulatory Macrophages before Kidney Transplantation
20180 citationsauthor #4
European Reflections on New Indications for Extracorporeal Photopheresis in Solid Organ Transplantation
20189 citationsauthor #2
Targeting Innate Immune Cells and Regulated Cell Death in Early Hepatic Ischemia Reperfusion Injury
20181 citationsauthor #7
Predicting Early Viral Control under DAA Therapy for Chronic HCV Using Pretreatment Immunological Markers
20180 citationsauthor #12
New Insights from the SILVER Study; A 50 % Reduction in Calcineurin Inhibitors at Day 30 Achieves a Temporary Renal-Sparing Effect but Does not Impact on Long-Term Renal Function after Liver Transplantation
20180 citationsauthor #5
Extracellular Citrate and Cancer Metabolism-Response.
20185 citationsauthor #2
Reply to "How Far can we Expand Donor Age Criteria for Pancreas Transplantation?"
20180 citationsauthor #2
Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo.
201874 citationsauthor #24
Selenium-binding protein 1 is down-regulated in malignant melanoma
201830 citationsauthor #5
Early Enrichment and Restitution of the Peripheral Blood Treg Pool is Associated with Rejection-Free Stable Immunosuppression After Liver Transplantation
20180 citationsauthor #6
C5aR1 governs Mreg migration, development, and function
20182 citationsauthor #2
Postoperative cellular stress in the kidney is associated with an early systemic γδ T-cell immune cell response
201818 citationsauthor #8
The Authors' Reply.
20180 citationsauthor #2
Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis
201826 citationsauthor #9
Immunological investigations empower transplant drug trials.
20184 citationsauthor #1
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
201849 citationsauthor #17
HCC recurrence in HCV patients after liver transplantation in the DAA treatment era: SiLVER Study subgroup analysis reveals sirolimus treatment in combination with CNIs is an excellent treatment option
20180 citationsauthor #6
BTNL8 is Expressed by Human Mreg-induced FOXP3+ iTregs
20181 citationsauthor #3
Extended Pancreas Donor Program—The EXPAND Study: A Prospective Multicenter Trial Testing the Use of Pancreas Donors Older Than 50 Years
201839 citationsauthor #17
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
2017317 citationsauthor #4
DHRS9 Is a Stable Marker of Human Regulatory Macrophages
201768 citationsauthor #15
Donor-specific Anti-HLA Antibodies Present in Pooled Human Serum Do Not Prevent Development of Human Mreg_UKR From Monocytes in Culture.
20174 citationsauthor #6
Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models
201746 citationsauthor #9
UK ethics response process time
20170 citationsauthor #1
Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation
201723 citationsauthor #23
Bile duct regeneration and immune response by passenger lymphocytes signals biliary recovery versus complications after liver transplantation
20175 citationsauthor #3
Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function.
201787 citationsauthor #20
Advances in Organ Transplant
20170 citationsauthor #2
Institutional Repository Single cell tracking of gadolinium labeled CD 4 ( + ) T cells by laser ablation inductively coupled plasma mass spectrometry
20171 citationsauthor #5
ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) does not affect proliferation, apoptosis, or angiogenesis as compared to standard liver resection for colorectal liver metastases
20178 citationsauthor #6
MITAP‐compliant characterization of human regulatory macrophages
201726 citationsauthor #3
The UK ONE Study: Safety and Feasibility of Regulatory T Cell Therapy in Renal Transplantation.
20162 citationsauthor #7
RORγt(+) IL-22-producing NKp46(+) cells protect from hepatic ischemia reperfusion injury in mice.
201621 citationsauthor #8
First Publication of Standardized Immune Monitoring Methods From the Virtual Global Transplantation Laboratory Initiative
20160 citationsauthor #1
Transplantation Reaches 100th Volume.
20162 citationsauthor #4
EXTENDED PANCREAS DONOR PROGRAM - THE EXPAND STUDY: A PROSPECTIVE MULTICENTER TRIAL TESTING THE USE OF PANCREAS DONORS OVER AGE 50
20163 citationsauthor #16
Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma
20166 citationsauthor #7
Receptor tyrosine kinase inhibitors: Are they real tumor killers?
201629 citationsauthor #5
Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story?
20161 citationsauthor #1
Early Enrichment and Restitution of the Peripheral Blood Treg Pool Is Associated With Rejection-Free Stable Immunosuppression After Liver Transplantation.
201610 citationsauthor #7
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.
20161,569 citationsauthor #26
Subcutaneous Murine Xenograft Models: A Critical Tool for Studying Human Tumor Growth and Angiogenesis In Vivo.
201612 citationsauthor #2
The UK ONE Study trial: safety and feasibility of regulatory T (Treg) cell therapy in renal transplantation
20161 citationsauthor #10
IRAK-M Expression in Tumor Cells Supports Colorectal Cancer Progression through Reduction of Antimicrobial Defense and Stabilization of STAT3.
201676 citationsauthor #17
Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells
201633 citationsauthor #7

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT